Comment on Roche paying $2.4B to acquire rest of US-based Foundation Medicine

Roche paying $2.4B to acquire rest of US-based Foundation Medicine

Swiss drugmaker Roche's $2.4 billion deal for U.S.-based Foundation Medicine represents an increased bet on gene-guided treatments to fight cancers. The agreement represents a a 29% premium over the June 18 value of Foundation Medicine's shares.        

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Movies News